See how top analysts and institutions rate JD — including buy, hold, and sell recommendations.
| Rating Source | Action | Rating | Target Price | Updated |
|---|---|---|---|---|
| Arete | Upgrade | Sell → Buy | $41 | 2025-09-26 |
| Citigroup | Resumed | Buy | $42 | 2025-08-11 |
| Arete | Downgrade | Buy → Neutral | $45 | 2025-06-24 |
| Date | Strong Buy | Buy | Hold | Sell | Strong Sell |
|---|---|---|---|---|---|
| November 2025 | 5 | 30 | 3 | 0 | 0 |
| October 2025 | 5 | 30 | 3 | 0 | 0 |
| September 2025 | 5 | 30 | 3 | 0 | 0 |
| August 2025 | 5 | 29 | 3 | 1 | 0 |
The majority of institutional investors have issued a "Buy" rating for JD, and analyst sentiment aligns closely, with very few "Sell" recommendations. This suggests a broadly favorable outlook for the stock's performance.
